Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model

British Journal of Surgery

Volumn 97, Issue 12, 2010, Pages 1874-1880

  Klaver, Y L B ^a   Hendriks, T ^b   Lomme, R M L M ^b   Rutten, H J T ^a   Bleichrodt, R P ^b   De Hingh, I H J T ^a  

^a CATHARINA HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MITOMYCIN;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; COLORECTAL TUMOR; HYPERTHERMIC THERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METASTASIS; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PERITONEUM TUMOR; RANDOMIZATION; RAT; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; HYPERTHERMIA, INDUCED; INJECTIONS, INTRAPERITONEAL; MALE; MITOMYCIN; NEOPLASM TRANSPLANTATION; PERITONEAL NEOPLASMS; RANDOM ALLOCATION; RATS;

EID: 78449292113     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7249     Document Type: Article

References (25)

1. Jayne DG, Fook S, Loi C, Seow-Choen F,. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002; 89: 1545-1550.
2. Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP,. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 2006; 243: 212-222.
3. Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC,. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989; 63: 364-367.
4. Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, et al., Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 2000; 88: 358-363.
5. Bloemendaal AL, Verwaal VJ, van Ruth S, Boot H, Zoetmulder FA,. Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study. Eur J Surg Oncol 2005; 31: 1145-1151.
6. Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al., Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21: 3737-3743.
7. Khatri VP,. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a panacea or just an obstacle course for the patient? J Clin Oncol 2010; 28: 5-7.
8. Yan TD, Zappa L, Edwards G, Alderman R, Marquardt CE, Sugarbaker PH,. Perioperative outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy for non-appendiceal peritoneal carcinomatosis from a prospective database. J Surg Oncol 2007; 96: 102-112. (Pubitemid 47264812)
9. Verwaal VJ, van Tinteren H, van Ruth SV, Zoetmulder FA,. Toxicity of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol 2004; 85: 61-67.
10. Elias D, Delperro JR, Sideris L, Benhamou E, Pocard M, Baton O, et al., Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials. Ann Surg Oncol 2004; 11: 518-521.
11. Zedeck MS, Sternberg SS,. A model system for studies of colon carcinogenesis: tumor induction by a single injection of methylazoxymethanol acetate. J Natl Cancer Inst 1974; 53: 1419-1421.
12. Lopes Cardozo AM, Gupta A, Koppe MJ, Meijer S, van Leeuwen PA, Beelen RJ, et al., Metastatic pattern of CC531 colon carcinoma cells in the abdominal cavity: an experimental model of peritoneal carcinomatosis in rats. Eur J Surg Oncol 2001; 27: 359-363.
13. Aarts F, Hendriks T, Boerman OC, Koppe MJ, Oyen WJ, Bleichrodt RP,. A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats. Ann Surg Oncol 2007; 14: 3274-3282.
14. Aarts F, Koppe MJ, Hendriks T, van Eerd JE, Oyen WJ, Boerman OC, et al., Timing of adjuvant radioimmunotherapy after cytoreductive surgery in experimental peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 2007; 14: 533-540.
15. Koppe MJ, Hendriks T, Boerman OC, Oyen WJ, Bleichrodt RP,. Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis. J Nucl Med 2006; 47: 1867-1874.
16. Los G, Ruevekamp M, Bosnie N, De Graaf PW, McVie JG,. Intraperitoneal tumor growth and chemotherapy in a rat model. Eur J Cancer Clin Oncol 1989; 25: 1857-1866.
17. Dirix LY, Gheuens EE, van der Heyden S, van Oosterom AT, De Bruijn EA,. Cytotoxic activity of 7-N-(2-((2-(-gamma- L -glutamylamino)-ethyl)dithio)ethyl)- mitomycin C and metabolites in cell lines with different resistance patterns. Anticancer Drugs 1994; 5: 343-354.
18. Aarts F, Bleichrodt RP, de Man B, Lomme R, Boerman OC, Hendriks T,. The effects of adjuvant experimental radioimmunotherapy and hyperthermic intraperitoneal chemotherapy on intestinal and abdominal healing after cytoreductive surgery for peritoneal carcinomatosis in the rat. Ann Surg Oncol 2008; 15: 3299-3307.
19. Pelz JO, Doerfer J, Hohenberger W, Meyer T,. A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis. BMC Cancer 2005; 5: 56.
20. Yan TD, Sim J, Morris DL,. Selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol 2007; 14: 1807-1817.
21. Verwaal VJ, van Tinteren H, van Ruth S, Zoetmulder FA,. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg 2004; 91: 739-746. (Pubitemid 38746143)
22. Benoit L, Duvillard C, Beltramo JL, Brunet-Lecomte P, Chauffert B,. [Intraperitoneal cisplatin plus epinephrine and surgical debulking for the treatment of advanced peritoneal carcinomatosis in the rat.] Gastroenterol Clin Biol 2000; 24: 26-30.
23. Monneuse O, Mestrallet JP, Quash G, Gilly FN, Glehen O,. Intraperitoneal treatment with dimethylthioampal (DIMATE) combined with surgical debulking is effective for experimental peritoneal carcinomatosis in a rat model. J Gastrointest Surg 2005; 9: 769-774.
24. Raue W, Kilian M, Braumann C, Atanassow V, Makareinis A, Caldenas S, et al., Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model. Int J Colorectal Dis 2010; 25: 245-250.
25. Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbag G, et al., Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999; 6: 790-796.